Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Addus HomeCare
DA
DanielGC
Community Contributor
Quality at a Premium. A time to watch, not to buy?
Key Takeaways Consistent revenue growth, strong profitability, and a pristine balance sheet position Addus for sustained disciplined acquisitive growth and improved operational efficiency. The company's business model is resilient and defensive against cyclical downturns, making it a safe haven in times of economic uncertainty.
View narrative
US$154.56
FV
29.9% undervalued
intrinsic discount
14.72%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
12
users have followed this narrative
28 days ago
author updated this narrative
Grab Holdings
BL
BlackGoat
Community Contributor
GRAB: The Super-App at the Heart of Southeast Asia’s Digital Boom
Why I Began Following This Company… My interest in Grab begins with the region it calls home. Southeast Asia is entering a transformative decade: young, fast-growing, and increasingly digital.
View narrative
US$6.6
FV
4.2% undervalued
intrinsic discount
20.00%
Revenue growth p.a.
Set Fair Value
15
users have liked this narrative
0
users have commented on this narrative
23
users have followed this narrative
Updated
narrative
Verve Group
ME
MEB
Community Contributor
Verve Group to Surge with 51.61% Revenue Growth
Verve Group faces near-term skepticism following its FY25 Q2 report, which included a downward revision to full-year revenue guidance. But beneath the short-term noise lies a company undergoing a strategic inflection — one that positions it to capture outsized value in the post-cookie, privacy-first advertising economy.
View narrative
€6
FV
64.1% undervalued
intrinsic discount
58.08%
Revenue growth p.a.
Set Fair Value
2
users have liked this narrative
1
users have commented on this narrative
11
users have followed this narrative
15 days ago
author updated this narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Medexus Pharmaceuticals
AN
AnalystLowTarget
Consensus Narrative from 5 Analysts
Regulatory Pressure Will Limit Revenues While Allowing Cautious Recovery
Key Takeaways Exposure to drug pricing pressure and regulatory scrutiny may limit revenue growth and increase operational challenges, especially as compliance costs rise. Heavy reliance on a few high-margin therapies creates vulnerability to market shifts, pricing changes, and evolving treatment paradigms.
View narrative
CA$5.55
FV
46.5% undervalued
intrinsic discount
5.65%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
13 days ago
author updated this narrative
QuidelOrtho
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
Global Expansion And Decentralized Testing Will Unlock Future Potential
Key Takeaways Expansion into global and underpenetrated markets, alongside demographic trends, positions QuidelOrtho for sustained diagnostic demand and stable long-term revenue streams. Operational efficiency, high-value diagnostics innovation, and improved customer satisfaction enhance margins, market share, and resilience against future industry challenges.
View narrative
US$43.43
FV
32.0% undervalued
intrinsic discount
2.59%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
12 days ago
author updated this narrative
Repsol
AN
AnalystConsensusTarget
Consensus Narrative from 24 Analysts
Renewable Energy Expansion Will Unlock Future Value
Key Takeaways Expansion in renewables and strategic green hydrogen and biofuel investments are set to diversify revenue, stabilize earnings, and enable higher-margin growth in low-carbon markets. Portfolio optimization and technological upgrades should improve operational resilience, drive efficiency, and support stable earnings from both hydrocarbon and customer-focused divisions.
View narrative
€14.28
FV
4.0% overvalued
intrinsic discount
3.49%
Revenue growth p.a.
Set Fair Value
6
users have liked this narrative
0
users have commented on this narrative
59
users have followed this narrative
13 days ago
author updated this narrative
Veritone
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
AI Demand Will Transform Public Sector And Defense Markets
Key Takeaways Rising demand for AI analytics and major government contracts are fueling growth, strengthening Veritone's positioning in both commercial and public sector markets. Emphasis on scalable, flexible platforms and cost-reduction initiatives supports improving margins, higher-value SaaS revenue, and a path toward profitability.
View narrative
US$5.25
FV
29.0% undervalued
intrinsic discount
20.22%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
11
users have followed this narrative
12 days ago
author updated this narrative
Cochin Shipyard
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Digital Upgrades And HD KSOE Ties Will Balance Overvaluation Risks
Key Takeaways Slow adoption of digital and modular technologies and over-optimistic valuations could limit productivity gains and future competitiveness versus global peers. High-margin project wind-down, rising global protectionism, and competitive pricing pressures pose risks to revenue growth and margin sustainability.
View narrative
₹1.26k
FV
44.3% overvalued
intrinsic discount
11.33%
Revenue growth p.a.
Set Fair Value
2
users have liked this narrative
0
users have commented on this narrative
25
users have followed this narrative
13 days ago
author updated this narrative
PROCEPT BioRobotics
AN
AnalystLowTarget
Consensus Narrative from 10 Analysts
Competitive Pressures Will Hinder Urologic Procedures Yet Spur Progress
Key Takeaways Growth potential driven by demographic trends and innovation faces threats from competition, pricing pressure, and possible market shifts to non-device treatments. Expansion and recurring revenue are promising, but high costs, reimbursement risks, and geopolitical factors could constrain margins and profitability.
View narrative
US$51
FV
22.4% undervalued
intrinsic discount
26.89%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
13 days ago
author updated this narrative
Techtronic Industries
AN
AnalystConsensusTarget
Consensus Narrative from 17 Analysts
Global Urbanization And Battery Trends Will Unlock Market Potential
Key Takeaways Strong demand growth, innovation in cordless tools, and expansion into new markets are driving significant revenue and market share gains for Techtronic Industries. Strategic investments in AI, advanced batteries, and supply chain automation are supporting higher margins, recurring revenue, and sustained long-term earnings growth.
View narrative
HK$116.14
FV
15.3% undervalued
intrinsic discount
7.88%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
13 days ago
author updated this narrative
Madrigal Pharmaceuticals
AN
AnalystLowTarget
Consensus Narrative from 13 Analysts
US Pricing Pressure And European Payers Will Erode Margins
Key Takeaways Heavy dependence on a single asset and aggressive market competition threaten both revenue growth and long-term market share. Expansion into Europe and persistent high expenses are likely to strain margins and hinder profitability due to pricing pressures and limited pipeline diversity.
View narrative
US$311.98
FV
36.9% overvalued
intrinsic discount
56.73%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
13 days ago
author updated this narrative
Safilo Group
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
Persistent Competition And Aging Demographics Will Curtail Profitability
Key Takeaways Intensifying online competition and demographic shifts threaten Safilo's traditional revenue streams and weaken growth prospects in key markets. Heavy dependence on licensed brands and slow adaptation to industry trends expose the company to revenue instability and erosion of profitability.
View narrative
€1
FV
57.0% overvalued
intrinsic discount
3.12%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
13 days ago
author updated this narrative